Cargando…

Therapeutic anticoagulation using heparin in early phase severe coronavirus disease 2019: A retrospective study

BACKGROUND: Although several reports recommend the use of systemic anticoagulation therapy in patients with severe coronavirus disease 2019 (COVID-19) pneumonia, appropriate target population and timing of administration are unknown. We assessed association between therapeutic anticoagulation admini...

Descripción completa

Detalles Bibliográficos
Autores principales:	Takayama, Wataru, Endo, Akira, Otomo, Yasuhiro
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Authors. Published by Elsevier Inc. 2022
Materias:	Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9135498/ https://www.ncbi.nlm.nih.gov/pubmed/35640454 http://dx.doi.org/10.1016/j.ajem.2022.05.031

Ejemplares similares

Anticoagulation therapy using unfractionated heparin at a therapeutic dose for coronavirus disease 2019 patients with severe pneumonia: a retrospective historical control study
por: Takayama, Wataru, et al.
Publicado: (2021)

The impact of blood type O on mortality of severe trauma patients: a retrospective observational study
por: Takayama, Wataru, et al.
Publicado: (2018)

Dielectric Blood Coagulometry for the Early Detection of Sepsis-Induced Disseminated Intravascular Coagulation: A Prospective Observational Study
por: Takayama, Wataru, et al.
Publicado: (2021)

A Case of Impalement Brain Injury That Could Achieve Good Neurological Outcome by Introducing Early Sedation and Immobilization Strategy
por: Takayama, Wataru, et al.
Publicado: (2018)

Manual Chest Compression versus Automated Chest Compression Device during Day-Time and Night-Time Resuscitation Following Out-of-Hospital Cardiac Arrest: A Retrospective Historical Control Study
por: Takayama, Wataru, et al.
Publicado: (2023)

Decreased mortality among hospitalized coronavirus disease 2019 patients who underwent anticoagulant therapy with heparin
por: Yethindra, Vityala, et al.
Publicado: (2020)

The impact of lactate clearance on outcomes according to infection sites in patients with sepsis: a retrospective observational study
por: Sugimoto, Momoko, et al.
Publicado: (2021)

Cardiopulmonary Resuscitation: Let’s Together Step into a New Era!
por: Takayama, Wataru, et al.
Publicado: (2022)

Comparative effectiveness of elemental formula in the early enteral nutrition management of acute pancreatitis: a retrospective cohort study
por: Endo, Akira, et al.
Publicado: (2018)

Severe COVID-19 Pneumonia in a 30-Year-Old Woman in the 36(th) Week of Pregnancy Treated with Postpartum Extracorporeal Membrane Oxygenation
por: Takayama, Wataru, et al.
Publicado: (2020)

Volume-outcome relationship on survival and cost benefits in severe burn injury: a retrospective analysis of a Japanese nationwide administrative database
por: Endo, Akira, et al.
Publicado: (2019)

Clinical Outcomes With the Use of Prophylactic Versus Therapeutic Anticoagulation in Coronavirus Disease 2019
por: Motta, Jishu Kaul, et al.
Publicado: (2020)

Physician-led prehospital management is associated with reduced mortality in severe blunt trauma patients: a retrospective analysis of the Japanese nationwide trauma registry
por: Endo, Akira, et al.
Publicado: (2021)

Therapeutic Anticoagulation with Heparin in Critically Ill Patients with Covid-19
Publicado: (2021)

Therapeutic Anticoagulation with Heparin in Noncritically Ill Patients with Covid-19
Publicado: (2021)

CRITICALLY ILL COVID-19 PATIENTS AND THERAPEUTIC ANTICOAGULATION WITH HEPARIN
por: Vu, Michael, et al.
Publicado: (2022)

Anticoagulation Management in Severe Coronavirus Disease 2019 Patients on Extracorporeal Membrane Oxygenation
por: Guo, Zhen, et al.
Publicado: (2021)

An Experience of Multiple Hematomas in a Coronavirus Disease-19 Patient Administered with ART-123 and Heparin
por: Shiraki, Hideto, et al.
Publicado: (2021)

Incidence of heparin-induced thrombocytopenia in patients with 2019 coronavirus disease()
por: Lozano, Roberto, et al.
Publicado: (2020)

Heparin or nonheparin anticoagulants for VITT
por: Arnold, Donald M.
Publicado: (2022)

Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy
por: Tang, Ning, et al.
Publicado: (2020)

Argatroban for therapeutic anticoagulation for heparin resistance associated with Covid-19 infection
por: McGlynn, Fergal, et al.
Publicado: (2020)

Severe pancreatic injury with total disruption of main pancreatic duct successfully managed by multi‐stage endoscopic therapy: a case report
por: Ito, Kei, et al.
Publicado: (2022)

Engineered heparins as new anticoagulant drugs
por: Vaidyanathan, Deepika, et al.
Publicado: (2016)

Non-Anticoagulant Heparins as Heparanase Inhibitors
por: Cassinelli, Giuseppe, et al.
Publicado: (2020)

Reply to “Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy”
por: Coto‐Hernández, Rubén, et al.
Publicado: (2020)

How to assess hypercoagulability in heparin-induced thrombocytopenia? Biomarkers of potential value to support therapeutic intensity of non-heparin anticoagulation
por: Barocas, Antoine, et al.
Publicado: (2023)

Heparin anticoagulation versus regional citrate anticoagulation for membrane therapeutic plasma exchange in patients with increased bleeding risk
por: Jiao, Jing, et al.
Publicado: (2023)

Regional citrate anticoagulation versus low molecular weight heparin anticoagulation for continuous venovenous hemofiltration in patients with severe hypercalcemia: a retrospective cohort study
por: Yu, Yan, et al.
Publicado: (2020)

Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
por: Kameda, Shinya, et al.
Publicado: (2023)

Usefulness of resuscitative endovascular balloon occlusion of the aorta compared to aortic cross‐clamping in severely injured trauma patients: Analysis from the Japan Trauma Data Bank
por: Haruta, Koichi, et al.
Publicado: (2023)

Argatroban therapy for heparin-induced thrombocytopenia in a patient with coronavirus disease 2019
por: Ogawa, Yoshihiko, et al.
Publicado: (2020)

Heparin for patients with coronavirus disease 2019 and hypercoagulation complications: A cohort study
por: Fachri, Muhammad, et al.
Publicado: (2022)

A case of severe COVID-19 with pulmonary thromboembolism related to heparin-induced thrombocytopenia during prophylactic anticoagulation therapy
por: Sasaki, Kosaku, et al.
Publicado: (2022)

The impact of blood type on the mortality of patients with severe abdominal trauma: a multicenter observational study
por: Takayama, Wataru, et al.
Publicado: (2021)

Early administration of glucocorticoid for thyroid storm: analysis of a national administrative database
por: Senda, Atsushi, et al.
Publicado: (2020)

Correction: Unfractionated heparin versus nafamostat mesylate for anticoagulation during continuous kidney replacement therapy: an observational study
por: Kameda, Shinya, et al.
Publicado: (2023)

The National Early Warning Score on admission predicts severe disease and in‐hospital mortality of the coronavirus disease 2019 Delta variant: A retrospective cohort study
por: Endo, Takuro, et al.
Publicado: (2023)

Response to 'Reply to Anticoagulant treatment is associated with decreased mortality in severe coronavirus disease 2019 patients with coagulopathy'
por: Tang, Ning
Publicado: (2020)

Time in the Therapeutic Range for Assessing Anticoagulation Quality in Patients Receiving Continuous Unfractionated Heparin
por: Ting, Clara, et al.
Publicado: (2018)

Cannot write session to /tmp/vufind_sessions/sess_gfc6s5gmtbama8pchngdsdnfj6